| Product Code: ETC9937670 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Angioedema Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Angioedema Market - Industry Life Cycle |
3.4 United Kingdom (UK) Angioedema Market - Porter's Five Forces |
3.5 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United Kingdom (UK) Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United Kingdom (UK) Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of angioedema in the UK |
4.2.2 Growing awareness about angioedema among healthcare professionals and patients |
4.2.3 Technological advancements in diagnostics and treatment options for angioedema |
4.3 Market Restraints |
4.3.1 High cost of treatment for angioedema |
4.3.2 Limited availability of specialized healthcare facilities for angioedema management in certain regions of the UK |
5 United Kingdom (UK) Angioedema Market Trends |
6 United Kingdom (UK) Angioedema Market, By Types |
6.1 United Kingdom (UK) Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 United Kingdom (UK) Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 United Kingdom (UK) Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 United Kingdom (UK) Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 United Kingdom (UK) Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 United Kingdom (UK) Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 United Kingdom (UK) Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 United Kingdom (UK) Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 United Kingdom (UK) Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 United Kingdom (UK) Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 United Kingdom (UK) Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 United Kingdom (UK) Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 United Kingdom (UK) Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 United Kingdom (UK) Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 United Kingdom (UK) Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United Kingdom (UK) Angioedema Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Angioedema Market Export to Major Countries |
7.2 United Kingdom (UK) Angioedema Market Imports from Major Countries |
8 United Kingdom (UK) Angioedema Market Key Performance Indicators |
8.1 Number of patients diagnosed with angioedema annually in the UK |
8.2 Adoption rate of new treatment options for angioedema |
8.3 Patient satisfaction with access to angioedema care services in the UK |
9 United Kingdom (UK) Angioedema Market - Opportunity Assessment |
9.1 United Kingdom (UK) Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 United Kingdom (UK) Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 United Kingdom (UK) Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 United Kingdom (UK) Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United Kingdom (UK) Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United Kingdom (UK) Angioedema Market - Competitive Landscape |
10.1 United Kingdom (UK) Angioedema Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here